Sex‐ and site‐specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort
Robin Reichmann,Katharina Nimptsch,Tobias Pischon,Marc J. Gunter,Mazda Jenab,Anne Kirstine Eriksen,Anne Tjonneland,Jürgen Janke,Verena Katzke,Rudolf Kaaks,Matthias B. Schulze,Fabian Eichelmann,Giovanna Masala,Sabina Sieri,Fabrizio Pasanisi,Rosario Tumino,Maria Teresa Giraudo,Joseph Rothwell,Gianluca Severi,Paula Jakszyn,Maria Jose Sanchez‐Perez,Pilar Amiano,Sandra M. Colorado‐Yohar,Marcela Guevara,Bethany van Guelpen,Elom K. Aglago,Alicia K. Heath,Karl Smith‐Byrne,Elisabete Weiderpass,Krasimira Aleksandrova
DOI: https://doi.org/10.1002/ijc.35205
2024-11-09
International Journal of Cancer
Abstract:What's New? Chronic inflammation can lead to cancer, particularly in the colon, and a glycoprotein associated with inflammation, lipocalin‐2 (LCN2), has been implicated in cancer progression. Here, using data from the European Prospective Investigation into Cancer and Nutrition cohort (EPIC), the authors show that higher levels of circulating LCN2 are associated with an increased risk of colon cancer in women. No association was seen in men. The association was particularly pronounced in people with higher waist circumference and for cancers arising in the proximal colon. Experimental research has uncovered lipocalin 2 (LCN2) as a novel biomarker implicated in the modulation of intestinal inflammation, metabolic homeostasis, and colon carcinogenesis. However, evidence from human research has been scant. We, therefore, explored the association of pre‐diagnostic circulating LCN2 concentrations with incident colorectal cancer (CRC) in a nested case–control study within the in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. LCN2 was measured in 1267 incident CRC cases matched to 1267 controls using incidence density sampling. Conditional logistic regression was used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) according to tumor subsite and sex. Weighted Cox proportional hazard regression was used to explore associations by adiposity status. In multivariable‐adjusted analyses, the IRR [95% CI] per doubling in LCN2 concentration was 1.16 [0.98–1.37] for CRC overall, 1.26 [1.00–1.59] for colon cancer, and 1.08 [0.85–1.38] for rectal cancer. The association for colon cancer was more pronounced in women (IRR [95% CI], 1.66 [1.20–2.30]) and for proximal colon cancer (IRR [95% CI], 1.96 [1.15–3.34]), whereas no association was seen in men and distal colon cancer. The association for colon cancer was positive in individuals with high waist circumference (hazard ratio [95% CI], 1.69 [1.52–1.88]) and inverse in individuals with low waist circumference (hazard ratio [95% CI], 0.86 [0.76–0.98], P interaction<0.01). Overall, these data suggest that pre‐diagnostic LCN2 concentrations were positively associated with colon cancer, particularly occurring in the proximal colon, in women and among individuals with abdominal adiposity.
oncology